Director, Health Economics and Outcomes Research (HEOR)

The role

This person will execute integrated global HEOR strategies across pipeline and marketed oncology products. They will drive evidence generation plans and develop methodologies to enhance the understanding of oncology treatment value.

What you will do

• Execute integrated global HEOR strategies across pipeline and marketed oncology products
• Drive execution of end-to-end evidence generation plans across the product lifecycle
• Execute and oversee the development of ex-US value Dossiers
• Oversee the design and execution of real-world and observational studies
• Lead the development and adaptation of cost-effectiveness and budget impact models
• Lead the design and execution of indirect treatment comparisons and external control arm studies
• Oversee the development of systematic literature reviews and evidence syntheses
• Provide strategic input into HTA submissions and payer engagement
• Drive innovation by advancing methodological approaches in health economics, epidemiology, and outcomes research
• Identify and leverage appropriate real-world data sources and establish external partnerships

Required qualifications

• Applicants must be currently authorized to work in the United States on a full-time basis

Nice to have

• Proficiency in advanced statistical and modeling techniques for economic evaluation
• In-depth knowledge and ability to apply knowledge of US and global healthcare systems, global HTA requirements, and clinical development
• Generate peer-reviewed publications to communicate study findings
• Expertise in the preparation and delivery of high-quality, evidence-based health economic reports and presentations
• Strong project management skills
• Excellent communication and presentation skills
• Advanced degree (PhD, MSc, or equivalent) in health economics, public health, health policy, statistics, or a related field
• A focus on oncology is highly desirable
• At least 10 years of experience in HEOR, with a strong background in oncology
• Demonstrated ability to lead cross-functional initiatives and influence senior stakeholders

About the company

Corcept is focused on the science of cortisol. The company has a commercial portfolio including treatments for hypercortisolism and oncology.